Arcutis Biotherapeutics, Inc. License Agreements
3 Contracts & Agreements
- Option Notice and Amendment No. 2 to Exclusive Option and License Agreement, dated December 5, 2019, by and between Jiangsu Hengrui Medicine Co., Ltd. and the Registrant (Filed With SEC on January 6, 2020)
- Exclusive Option and License Agreement, dated January 4, 2018, by and between Jiangsu Hengrui Medicine Co., Ltd. and the Registrant (Filed With SEC on January 6, 2020)
- License Agreement, dated July 23, 2018, by and between AstraZeneca AB and the Registrant (Filed With SEC on January 6, 2020)
